271 related articles for article (PubMed ID: 37018873)
1. Sex and gender perspectives in colorectal cancer.
Baraibar I; Ros J; Saoudi N; Salvà F; García A; Castells MR; Tabernero J; Élez E
ESMO Open; 2023 Apr; 8(2):101204. PubMed ID: 37018873
[TBL] [Abstract][Full Text] [Related]
2. [Gender-specific influences on incidence, screening, treatment, and outcome of colorectal cancer].
Grundmann RT; Meyer F
Zentralbl Chir; 2013 Aug; 138(4):434-41. PubMed ID: 23950079
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Gender medicine and oncology: report and consensus of an ESMO workshop.
Wagner AD; Oertelt-Prigione S; Adjei A; Buclin T; Cristina V; Csajka C; Coukos G; Dafni U; Dotto GP; Ducreux M; Fellay J; Haanen J; Hocquelet A; Klinge I; Lemmens V; Letsch A; Mauer M; Moehler M; Peters S; Özdemir BC
Ann Oncol; 2019 Dec; 30(12):1914-1924. PubMed ID: 31613312
[TBL] [Abstract][Full Text] [Related]
5. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better.
Andrei P; Battuello P; Grasso G; Rovera E; Tesio N; Bardelli A
Semin Cancer Biol; 2022 Sep; 84():199-213. PubMed ID: 33848627
[TBL] [Abstract][Full Text] [Related]
6. Sex- and gender-specific disparities in colorectal cancer risk.
Kim SE; Paik HY; Yoon H; Lee JE; Kim N; Sung MK
World J Gastroenterol; 2015 May; 21(17):5167-75. PubMed ID: 25954090
[TBL] [Abstract][Full Text] [Related]
7. Optimizing targeted therapeutic development: analysis of a colorectal cancer patient population with the BRAF(V600E) mutation.
Tie J; Gibbs P; Lipton L; Christie M; Jorissen RN; Burgess AW; Croxford M; Jones I; Langland R; Kosmider S; McKay D; Bollag G; Nolop K; Sieber OM; Desai J
Int J Cancer; 2011 May; 128(9):2075-84. PubMed ID: 20635392
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance of Microsatellite Instability in Patients with Right-sided Colorectal Cancer.
Han SA; Kim JH; Choi JH; Lee DH; Jung K; Kim SE; Moon W; Park MI; Park SJ
Korean J Gastroenterol; 2019 Mar; 73(3):159-166. PubMed ID: 31013559
[TBL] [Abstract][Full Text] [Related]
9. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
10. Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study.
Brändstedt J; Wangefjord S; Nodin B; Eberhard J; Sundström M; Manjer J; Jirström K
PLoS One; 2014; 9(2):e98964. PubMed ID: 24918610
[TBL] [Abstract][Full Text] [Related]
11. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
Benedix F; Kuester D; Meyer F; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
[TBL] [Abstract][Full Text] [Related]
12. Sex and Gender Differences in Anticancer Treatment Toxicity: A Call for Revisiting Drug Dosing in Oncology.
Özdemir BC; Gerard CL; Espinosa da Silva C
Endocrinology; 2022 Jun; 163(6):. PubMed ID: 35560216
[TBL] [Abstract][Full Text] [Related]
13. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
14. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.
White A; Ironmonger L; Steele RJC; Ormiston-Smith N; Crawford C; Seims A
BMC Cancer; 2018 Sep; 18(1):906. PubMed ID: 30236083
[TBL] [Abstract][Full Text] [Related]
15. Sex Difference of Colon Adenoma Pathway and Colorectal Carcinogenesis.
Choi Y; Kim N
World J Mens Health; 2024 Apr; 42(2):256-282. PubMed ID: 37652658
[TBL] [Abstract][Full Text] [Related]
16. From tumour heterogeneity to advances in precision treatment of colorectal cancer.
Punt CJ; Koopman M; Vermeulen L
Nat Rev Clin Oncol; 2017 Apr; 14(4):235-246. PubMed ID: 27922044
[TBL] [Abstract][Full Text] [Related]
17. Precision oncology in metastatic colorectal cancer - from biology to medicine.
Di Nicolantonio F; Vitiello PP; Marsoni S; Siena S; Tabernero J; Trusolino L; Bernards R; Bardelli A
Nat Rev Clin Oncol; 2021 Aug; 18(8):506-525. PubMed ID: 33864051
[TBL] [Abstract][Full Text] [Related]
18. Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E; De Mattia E; Ecca F; Toffoli G
Drug Resist Updat; 2018 Jul; 39():18-40. PubMed ID: 30075835
[TBL] [Abstract][Full Text] [Related]
19. Genetics, sex, and gender.
Reale C; Invernizzi F; Panteghini C; Garavaglia B
J Neurosci Res; 2023 May; 101(5):553-562. PubMed ID: 34498752
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?
Keating J; Pater P; Lolohea S; Wickremesekera K
N Z Med J; 2003 May; 116(1174):U437. PubMed ID: 12766783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
